id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2009-N-0582-0017,FDA,FDA-2009-N-0582,"OMB Changes, Executive Order 12866 (E.O.)[Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner ] - Reference",Other,REF-Reference Material (internal attachments),2010-04-27T04:00:00Z,2010,4,2010-04-27T04:00:00Z,,2013-08-11T01:34:04Z,,0,0,0900006480ae15c4
FDA-2009-N-0582-0007,FDA,FDA-2009-N-0582,"Reference 12 - ""IMS Health, Total U.S. Promotional Spend By Type, 2008"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:20:19Z,,0,0,0900006480ac9fd4
FDA-2009-N-0582-0008,FDA,FDA-2009-N-0582,"Reference 13 - ""IMS Health, Integrated Promotional Services™, Year 2008, Data Extracted on September 2009"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:20:40Z,,0,0,0900006480ac9fd9
FDA-2009-N-0582-0009,FDA,FDA-2009-N-0582,"Reference 15 - ""Office of Management and Budget, Circular A-4, Setember 17, 2003"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:21:01Z,,0,0,0900006480ac9ffb
FDA-2009-N-0582-0013,FDA,FDA-2009-N-0582,"Reference 19 - ""Scientific Literature on Direct to Consumer Advertising of Precription Pharmaceuticals, 2004-2008; Eastern Research Group, Inc., Literature Review"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:22:43Z,,0,0,0900006480aca060
FDA-2009-N-0582-0003,FDA,FDA-2009-N-0582,"Reference 1 - ""FDA Guidance for Industry, ""Consumer-Directed Broadcast Advertisements,"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:18:52Z,,0,0,0900006480ac9f70
FDA-2009-N-0582-0002,FDA,FDA-2009-N-0582,DDMAC References -  [Note for MONDAY 3/29/2010 - POST THIS DOCUMENT FIRST BUT AFTER THE FR DOCUMENT AND Please Insert the Title of the FR Notice Here],Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:18:23Z,,0,0,0900006480aca149
FDA-2009-N-0582-0001,FDA,FDA-2009-N-0582,"Direct-to-Consumer Prescription Drug Advertisements: Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner",Proposed Rule,NPR-Notice of Proposed Rule-Making,2010-03-29T04:00:00Z,2010,3,2010-03-29T04:00:00Z,2010-06-29T03:59:59Z,2012-11-30T03:02:04Z,2010-06996,0,0,0900006480aca825
FDA-2009-N-0582-0010,FDA,FDA-2009-N-0582,"Reference 16 - ""Prescription Drugs: FDA Oversight of Direct-to-Consumer Advertising Has Limitations, GAO"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:21:25Z,,0,0,0900006480aca03c
FDA-2009-N-0582-0006,FDA,FDA-2009-N-0582,"Reference 4 - ""FDA Draft Guidance for Industry, ""Presenting Risk Information in Prescription Drug and Medical Device Promotion,"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:19:59Z,,0,0,0900006480ac9f89
FDA-2009-N-0582-0004,FDA,FDA-2009-N-0582,"Reference 2 - ""CCH Trade Regulation Reporter, Paragraph 7569.09 ""Clear and Conspicous Disclosure,"" Ocober 21, 1970 - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:19:13Z,,0,0,0900006480ac9f86
FDA-2009-N-0582-0011,FDA,FDA-2009-N-0582,"Reference 17 - ""PhRMA Guiding Priniciples; Direct to Consumer Advertisements About Prescription Medicines, Revised December 2008"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:21:45Z,,0,0,0900006480aca040
FDA-2009-N-0582-0012,FDA,FDA-2009-N-0582,"Reference 18 - ""Patient and Physician Attitudes and Behaviors Associated With DTC Promotion of Prescription Drugs--Summary of FDA Survey Research Results, Final Report, November 19, 2004"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:22:06Z,,0,0,0900006480aca044
FDA-2009-N-0582-0005,FDA,FDA-2009-N-0582,"Reference 3 - ""See H. Rept. No. 102-839, August 11, 1992"" - Background",Supporting & Related Material,BKG-Background Material,2010-03-29T04:00:00Z,2010,3,,,2010-03-29T15:19:36Z,,0,0,0900006480ac9f87